4D Molecular Therapeutics, Inc 10-Q for FY2023 Q3
4D Molecular Therapeutics, Inc. (FDMT)
10-Q
2023-11-09
For: 2023-09-30
View Original
Added on
April 08, 2026
About this 10-Q
4D Molecular Therapeutics, Inc filed this 10-Q on November 9, 2023, covering the quarter ended September 30, 2023 (FY2023 Q3).
Headline figures
Quarter ended September 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $20.2M
- up 3940.8% from $500K a year earlier
- Net loss
- $10.26M
- compared with a net loss of $25.69M a year earlier
- Diluted EPS
- -$0.24
- compared with -$0.79 a year earlier